Target intelligence / Profile preview

Neuronal dendritic signaling complex (PSD)

Target
PSD
Molecular classification
Protein complex, Receptor, Ion channel, Enzyme, Scaffolding protein
01

Overview

Neuronal dendritic signaling complexes are specialized protein assemblies located at the postsynaptic membrane of neurons, primarily within dendritic spines (Sheng & Kim, 2011). These complexes, often referred to as the postsynaptic density (PSD), serve as the primary site for integrating chemical signals from neurotransmitters into intracellular biochemical cascades (Kennedy, 2000). They consist of a dense network of ionotropic receptors (such as NMDA and AMPA receptors), metabotropic receptors, scaffolding proteins like PSD-95, and various signaling enzymes including kinases and phosphatases (Kaizuka & Takumi, 2018). The structural and functional integrity of these complexes is essential for synaptic plasticity, which underlies learning and memory processes (Citri & Malenka, 2008). Dysregulation or disassembly of these complexes is implicated in a wide range of CNS disorders, including ischemic stroke, where excitotoxic signaling through the PSD-95/NMDA receptor link leads to neuronal death (Hill et al., 2020). Therapeutic interventions targeting these complexes include small molecules and peptides, such as nerinetide, designed to disrupt specific pathological protein-protein interactions or modulate receptor activity to restore normal synaptic function (Sun et al., 2018).

Other names
Postsynaptic densityPSDDendritic signalosomeSynaptic signaling complexPostsynaptic signaling complex
02

Mechanism of action

Inhibition of protein-protein interactions (PPI) within the postsynaptic density; modulation of ionotropic and metabotropic receptor signaling.

03

Biological functions

Signal transductionSynaptic plasticityNeurotransmissionLong-term potentiation (LTP)
04

Disease associations

Ischemic strokeAlzheimer's diseaseSchizophreniaAutism spectrum disorderMajor depressive disorder
05

Safety considerations

Cognitive impairmentDissociative effectsDisruption of normal synaptic plasticityPotential for neurotoxicity if over-inhibited
06

Interacting drugs

Nerinetide (NA-1)

3 more in the full profile.

07

Biomarkers

Neurogranin (CSF)Synaptic vesicle protein 2A (SV2A) PET imagingPSD-95 levels

Beyond the preview

Go deeper on Neuronal dendritic signaling complex (PSD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal dendritic signaling complex (PSD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call